Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Coughing up a Cure for Whooping Cough with Pertussis Toxin

View through CrossRef
The CDC reported 32,971 cases of pertussis, or whooping cough, in 2014. This respiratory infection mainly affects unvaccinated infants and toddlers, and symptoms include paroxysmal coughing with whooping, vomiting, and pulmonary complications which can lead to death. Pertussis toxin (PT), produced by the pathogenic bacteria Bordetella pertussis , causes whooping cough by ADP‐ribosylating the G i protein that inactivates adenylyl cyclase. The inactive ADP‐ribosylated G i protein is unable to interact with G protein‐coupled receptors, leading to an increased intracellular concentration of cAMP. Increased concentrations of cAMP can interfere with normal cell signaling, disrupting specific cellular functions. PT is a critical virulence factor for B. pertussis that also has potential to create human immunity against pertussis. The Cedarburg SMART Team (Students Modeling A Research Topic) modeled PT using 3‐D printing technology to study structure‐function relationships. PT contains a total of six subunits, four individual subunits (S1, S2, S3, and S5) and a pair of identical subunits (S4). The A domain consists of the S1 subunit, the catalytic portion of the toxin. Mutations in Glu129 and His35 can reduce ADP‐ribosyltransferase activity. Mutations in Arg9, Asp11, and Arg13 also reduce catalytic activity. Trp26 interacts with NAD + , an important cofactor. The B domain, responsible for binding to cell receptors, contains the remaining subunits. Effective vaccines contain chemically‐inactivated PT. However, whole cell pertussis vaccine may cause severe side effects, while acellular pertussis vaccine is not as potent. Non‐toxic derivatives of pertussis toxin may be engineered, improving the potency of the acellular vaccine without harmful side effects. Support or Funding Information This work was supported by the National Institutes of of Health Science Education Partnership Award (NIH‐SEPA 1R25OD010505‐01) and the National Institutes of Health Clinical and Translational Science Award (NIH‐CTSA UL1RR031973).
Title: Coughing up a Cure for Whooping Cough with Pertussis Toxin
Description:
The CDC reported 32,971 cases of pertussis, or whooping cough, in 2014.
This respiratory infection mainly affects unvaccinated infants and toddlers, and symptoms include paroxysmal coughing with whooping, vomiting, and pulmonary complications which can lead to death.
Pertussis toxin (PT), produced by the pathogenic bacteria Bordetella pertussis , causes whooping cough by ADP‐ribosylating the G i protein that inactivates adenylyl cyclase.
The inactive ADP‐ribosylated G i protein is unable to interact with G protein‐coupled receptors, leading to an increased intracellular concentration of cAMP.
Increased concentrations of cAMP can interfere with normal cell signaling, disrupting specific cellular functions.
PT is a critical virulence factor for B.
pertussis that also has potential to create human immunity against pertussis.
The Cedarburg SMART Team (Students Modeling A Research Topic) modeled PT using 3‐D printing technology to study structure‐function relationships.
PT contains a total of six subunits, four individual subunits (S1, S2, S3, and S5) and a pair of identical subunits (S4).
The A domain consists of the S1 subunit, the catalytic portion of the toxin.
Mutations in Glu129 and His35 can reduce ADP‐ribosyltransferase activity.
Mutations in Arg9, Asp11, and Arg13 also reduce catalytic activity.
Trp26 interacts with NAD + , an important cofactor.
The B domain, responsible for binding to cell receptors, contains the remaining subunits.
Effective vaccines contain chemically‐inactivated PT.
However, whole cell pertussis vaccine may cause severe side effects, while acellular pertussis vaccine is not as potent.
Non‐toxic derivatives of pertussis toxin may be engineered, improving the potency of the acellular vaccine without harmful side effects.
Support or Funding Information This work was supported by the National Institutes of of Health Science Education Partnership Award (NIH‐SEPA 1R25OD010505‐01) and the National Institutes of Health Clinical and Translational Science Award (NIH‐CTSA UL1RR031973).

Related Results

MODERN EPIDEMIOLOGICAL AND ECONOMIC CHARACTERISTICS OF WHOOPING COUGH IN MOSCOW
MODERN EPIDEMIOLOGICAL AND ECONOMIC CHARACTERISTICS OF WHOOPING COUGH IN MOSCOW
The goal of the study was the identification of epidemiological features of whooping cough and assessment of economic losses due to this disease in Moscow.Materials and methods. Th...
Optimization of sample preparation for culture-independent sequencing of Bordetella pertussis
Optimization of sample preparation for culture-independent sequencing of Bordetella pertussis
Bordetella pertussis , the aetiological agent of whooping cough, is re-emerging globally despite widespread vaccination. ...
Pertussis in infants, in their mothers and other contacts in Casablanca, Morocco
Pertussis in infants, in their mothers and other contacts in Casablanca, Morocco
Abstract Background In recent decades, there has been a marked increase in the number of reported cases of pertussis around the world, and pertussis continues to be a frequently oc...
Profile of cough triggers and their relationship with capsaicin cough sensitivity in chronic cough
Profile of cough triggers and their relationship with capsaicin cough sensitivity in chronic cough
Background: Cough hypersensitivity is an important part of the neurophysiology of cough, which presents with increased cough response to a lower level of stimul...
Pertussis in Poland in 2022
Pertussis in Poland in 2022
IntroductionThe epidemiological situation of pertussis in Poland in 2022 was influenced by the cancellation of the COVID-19 epidemic and the introduction of an epidemic threat. Dec...
An exploration of clinically meaningful definitions of cough bouts
An exploration of clinically meaningful definitions of cough bouts
RationaleThe measurement of cough frequency is widely used in clinical trials, typically expressed as the number of explosive cough sounds per hour. However, this measure does not ...
Pertussis
Pertussis
The bacterium Bordetella pertussis causes disease by producing various virulence and adhesion factors, among them pertussis toxin (PT), filamentous hemagglutinin (FHA), pertactin (...
Pertussis
Pertussis
The bacterium Bordetella pertussis causes disease by producing various virulence and adhesion factors, among them pertussis toxin (PT), filamentous hemagglutinin (FHA), pertactin (...

Back to Top